| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |